Literature DB >> 10634416

Malignant prolactinoma discovered by D2 receptor imaging.

P Petrossians1, W de Herder, D Kwekkeboom, G Lamberigts, A Stevenaert, A Beckers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10634416     DOI： 10.1210/jcem.85.1.6253

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

1.  The epidemiology of prolactinomas.

Authors:  Antonio Ciccarelli; Adrian F Daly; Albert Beckers
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 2.  Progression on metastatic neuroendocrine carcinoma from a recurrent prolactinoma: a case report.

Authors:  M Sironi; G Cenacchi; L Cozzi; G Tonnarelli; M Iacobellis; D Treré; A Assi
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

Review 3.  Pituitary carcinoma: diagnosis and treatment.

Authors:  M Beatriz S Lopes; Bernd W Scheithauer; David Schiff
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

Review 4.  Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

Authors:  Albert Beckers; Lauri A Aaltonen; Adrian F Daly; Auli Karhu
Journal:  Endocr Rev       Date:  2013-01-31       Impact factor: 19.871

5.  Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation‒Positive Child.

Authors:  Pinaki Dutta; Kavita S Reddy; Ashutosh Rai; Anil K Madugundu; Hitendra S Solanki; Anil Bhansali; Bishan D Radotra; Narendra Kumar; David Collier; Donato Iacovazzo; Prakamya Gupta; Remya Raja; Harsha Gowda; Akhilesh Pandey; Jagtar Singh Devgun; Márta Korbonits
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.